Moreover, combining PPAR modulators with other therapeutic agents, such as anti-inflammatory biologics, immune checkpoint inhibitors, or metabolic drugs, could enhance treatment efficacy for complex diseases like atherosclerosis, diabetes, cancer, and autoimmune disorders. Here, PPARA is linked to atherosclerosis.